{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:25:24Z","timestamp":1792441524790,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,10]],"date-time":"2014-12-10T00:00:00Z","timestamp":1418169600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s12031-014-0476-3","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T01:58:37Z","timestamp":1418090317000},"page":"154-163","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Selected Extracellular microRNA as Potential Biomarkers of Multiple Sclerosis Activity\u2014Preliminary Study"],"prefix":"10.1007","volume":"56","author":[{"given":"Magdalena Justyna","family":"Kacperska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Jastrzebski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartlomiej","family":"Tomasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Walenczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Konarska-Krol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Glabinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,10]]},"reference":[{"issue":"21","key":"476_CR1","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1242\/dev.02073","volume":"132","author":"I Alvarez-Garcia","year":"2005","unstructured":"Alvarez-Garcia I, Miska EA (2005) MicroRNA functions in animal development and human disease. Development 132(21):4653\u20134662","journal-title":"Development"},{"issue":"2","key":"476_CR2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1073\/pnas.94.2.599","volume":"94","author":"KE Balashov","year":"1997","unstructured":"Balashov KE, Smith DR, Khoury SJ, Hafler DA, Weiner HL (1997) Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand. Proc Natl Acad Sci U S A 94(2):599\u2013603","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"476_CR3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/0888439002250449","volume":"17","author":"MP Barnes","year":"2003","unstructured":"Barnes MP, Kent RM, Semlyen JK, McMullen KM (2003) Spasticity in multiple sclerosis. Neurorehabil Neural Repair 17(1):66\u201370","journal-title":"Neurorehabil Neural Repair"},{"issue":"2","key":"476_CR4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281\u2013297","journal-title":"Cell"},{"issue":"2","key":"476_CR5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1261\/rna.5167604","volume":"10","author":"MT Bohnsack","year":"2004","unstructured":"Bohnsack MT, Czaplinski K, Gorlich D (2004) Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 10(2):185\u2013191","journal-title":"RNA"},{"issue":"4","key":"476_CR6","doi-asserted-by":"crossref","first-page":"S352","DOI":"10.1007\/s10072-008-1042-y","volume":"29","author":"G Popolo Del","year":"2008","unstructured":"Del Popolo G, Panariello G, Del Corso F, De Scisciolo G, Lombardi G (2008) Diagnosis and therapy for neurogenic bladder dysfunctions in multiple sclerosis patients. Neurol Sci 29(4):S352\u2013355","journal-title":"Neurol Sci"},{"issue":"7014","key":"476_CR7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature03049","volume":"432","author":"AM Denli","year":"2004","unstructured":"Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ (2004) Processing of primary microRNAs by the microprocessor complex. Nature 432(7014):231\u2013235","journal-title":"Nature"},{"issue":"24","key":"476_CR8","doi-asserted-by":"crossref","first-page":"8381","DOI":"10.1073\/pnas.0803454105","volume":"105","author":"Y Doi","year":"2008","unstructured":"Doi Y, Oki S, Ozawa T, Hohjoh H, Miyake S, Yamamura T (2008) Orphan nuclear receptor NR4A2 expressed in T cells from multiple sclerosis mediates production of inflammatory cytokines. Proc Natl Acad Sci U S A 105(24):8381\u20138386","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"476_CR9","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jbi.2011.05.002","volume":"44","author":"H Dweep","year":"2011","unstructured":"Dweep H, Sticht C, Pandey P, Gretz N (2011) miRWalk\u2013database: prediction of possible miRNA binding sites by \u201cwalking\u201d the genes of three genomes. J Biomed Inform 44(5):839\u2013847","journal-title":"J Biomed Inform"},{"issue":"10","key":"476_CR10","doi-asserted-by":"crossref","first-page":"13227","DOI":"10.3390\/ijms131013227","volume":"13","author":"C Fenoglio","year":"2012","unstructured":"Fenoglio C, Ridolfi E, Galimberti D, Scarpini E (2012) MicroRNAs as active players in the pathogenesis of multiple sclerosis. Int J Mol Sci 13(10):13227\u201313239","journal-title":"Int J Mol Sci"},{"issue":"6","key":"476_CR11","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ana.23880","volume":"73","author":"R Gandhi","year":"2013","unstructured":"Gandhi R, Healy B, Gholipour T et al (2013) Circulating microRNAs as biomarkers for disease staging in multiple sclerosis. Ann Neurol 73(6):729\u2013740","journal-title":"Ann Neurol"},{"issue":"Database issue","key":"476_CR12","first-page":"D154","volume":"36","author":"S Griffiths-Jones","year":"2008","unstructured":"Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36(Database issue):D154\u2013158","journal-title":"Nucleic Acids Res"},{"issue":"1\u20132","key":"476_CR13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jneuroim.2011.10.006","volume":"248","author":"M Guerau-de-Arellano","year":"2012","unstructured":"Guerau-de-Arellano M, Alder H, Ozer HG, Lovett-Racke A, Racke MK (2012) miRNA profiling for biomarker discovery in multiple sclerosis: from microarray to deep sequencing. J Neuroimmunol 248(1\u20132):32\u201339","journal-title":"J Neuroimmunol"},{"key":"476_CR14","first-page":"40","volume":"6","author":"SM Heman-Ackah","year":"2013","unstructured":"Heman-Ackah SM, Hallegger M, Rao MS, Wood MJ (2013) RISC in PD: the impact of microRNAs in Parkinson\u2019s disease cellular and molecular pathogenesis. Front Mol Neurosci 6:40","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"476_CR15","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.imlet.2007.12.008","volume":"116","author":"MM Juntilla","year":"2008","unstructured":"Juntilla MM, Koretzky GA (2008) Critical roles of the PI3K\/Akt signaling pathway in T cell development. Immunol Lett 116(2):104\u2013110","journal-title":"Immunol Lett"},{"issue":"7","key":"476_CR16","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1212\/01.wnl.0000237641.33768.8d","volume":"67","author":"L Kappos","year":"2006","unstructured":"Kappos L, Polman CH, Freedman MS et al (2006) Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 67(7):1242\u20131249","journal-title":"Neurology"},{"issue":"4","key":"476_CR17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.autrev.2009.08.002","volume":"9","author":"N Kaushansky","year":"2010","unstructured":"Kaushansky N, Eisenstein M, Zilkha-Falb R, Ben-Nun A (2010) The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis. Autoimmun Rev 9(4):233\u2013236","journal-title":"Autoimmun Rev"},{"issue":"9","key":"476_CR18","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg2843","volume":"11","author":"J Krol","year":"2010","unstructured":"Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11(9):597\u2013610","journal-title":"Nat Rev Genet"},{"issue":"11","key":"476_CR19","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1212\/WNL.45.11.1956","volume":"45","author":"LB Krupp","year":"1995","unstructured":"Krupp LB, Coyle PK, Doscher C et al (1995) Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology 45(11):1956\u20131961","journal-title":"Neurology"},{"issue":"5","key":"476_CR20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0028-3843(14)60134-1","volume":"44","author":"A Kulakowska","year":"2010","unstructured":"Kulakowska A, Bartosik-Psujek H, Hozejowski R, Mitosek-Szewczyk K, Drozdowski W, Stelmasiak Z (2010) Selected aspects of the epidemiology of multiple sclerosis in Poland\u2014a multicentre pilot study. Neurol Neurochir Pol 44(5):443\u2013452","journal-title":"Neurol Neurochir Pol"},{"issue":"6","key":"476_CR21","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nn.3113","volume":"15","author":"SM Lehmann","year":"2012","unstructured":"Lehmann SM, Kruger C, Park B et al (2012) An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat Neurosci 15(6):827\u2013835","journal-title":"Nat Neurosci"},{"issue":"4","key":"476_CR22","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","volume":"46","author":"FD Lublin","year":"1996","unstructured":"Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) advisory committee on clinical trials of new agents in multiple sclerosis. Neurology 46(4):907\u2013911","journal-title":"Neurology"},{"issue":"5","key":"476_CR23","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/WNL.49.5.1404","volume":"49","author":"Optic Neuritis Study Group","year":"1997","unstructured":"Optic Neuritis Study Group (1997) The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial. Neurology 49(5):1404\u20131413","journal-title":"Neurology"},{"issue":"2","key":"476_CR24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.critrevonc.2010.11.004","volume":"80","author":"G Reid","year":"2011","unstructured":"Reid G, Kirschner MB, van Zandwijk N (2011) Circulating microRNAs: association with disease and potential use as biomarkers. Crit Rev Oncol Hematol 80(2):193\u2013208","journal-title":"Crit Rev Oncol Hematol"},{"issue":"10","key":"476_CR25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.tcb.2008.07.007","volume":"18","author":"S Roush","year":"2008","unstructured":"Roush S, Slack FJ (2008) The let-7 family of microRNAs. Trends Cell Biol 18(10):505\u2013516","journal-title":"Trends Cell Biol"},{"issue":"2","key":"476_CR26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0092-8674(03)00759-1","volume":"115","author":"DS Schwarz","year":"2003","unstructured":"Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD (2003) Asymmetry in the assembly of the RNAi enzyme complex. Cell 115(2):199\u2013208","journal-title":"Cell"},{"issue":"5","key":"476_CR27","doi-asserted-by":"crossref","first-page":"6219","DOI":"10.1007\/s11033-011-1441-7","volume":"39","author":"SR Siegel","year":"2012","unstructured":"Siegel SR, Mackenzie J, Chaplin G, Jablonski NG, Griffiths L (2012) Circulating microRNAs involved in multiple sclerosis. Mol Biol Rep 39(5):6219\u20136225","journal-title":"Mol Biol Rep"},{"key":"476_CR28","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","volume":"23","author":"M Sospedra","year":"2005","unstructured":"Sospedra M, Martin R (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23:683\u2013747","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"476_CR29","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.4049\/jimmunol.1101196","volume":"188","author":"S Swaminathan","year":"2012","unstructured":"Swaminathan S, Suzuki K, Seddiki N et al (2012) Differential regulation of the let-7 family of microRNAs in CD4+ T cells alters IL-10 expression. J Immunol 188(12):6238\u20136246","journal-title":"J Immunol"},{"issue":"5700","key":"476_CR30","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1126\/science.1102755","volume":"306","author":"Y Tomari","year":"2004","unstructured":"Tomari Y, Matranga C, Haley B, Martinez N, Zamore PD (2004) A protein sensor for siRNA asymmetry. Science 306(5700):1377\u20131380","journal-title":"Science"},{"issue":"12","key":"476_CR31","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1111\/j.1349-7006.2011.02081.x","volume":"102","author":"A Tsuchida","year":"2011","unstructured":"Tsuchida A, Ohno S, Wu W et al (2011) miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer. Cancer Sci 102(12):2264\u20132271","journal-title":"Cancer Sci"},{"issue":"4","key":"476_CR32","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00018-007-7355-9","volume":"65","author":"AE Williams","year":"2008","unstructured":"Williams AE (2008) Functional aspects of animal microRNAs. Cell Mol Life Sci 65(4):545\u2013562","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"476_CR33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ni1575","volume":"9","author":"C Xiao","year":"2008","unstructured":"Xiao C, Srinivasan L, Calado DP et al (2008) Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 9(4):405\u2013414","journal-title":"Nat Immunol"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-014-0476-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-014-0476-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-014-0476-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T08:02:05Z","timestamp":1566115325000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-014-0476-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,10]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["476"],"URL":"https:\/\/doi.org\/10.1007\/s12031-014-0476-3","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,10]]}}}